http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2865034-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_997f86aae915f2aabd265e260bd0cfbf |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2004-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a64a53e2f159857ca38f192e1c11956 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_675ba24e761bd6cc896db6f5513802fe |
publicationDate | 2005-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | FR-2865034-A1 |
titleOfInvention | METHOD FOR EVALUATING THE DEGRADATION OF CARTILAGINOUS TISSUE OF AN INDIVIDUAL |
abstract | Method for evaluating the degradation of the cartilage tissue of an individual from the in vitro detection in a biological sample from the individual, of the level of at least one specific marker of the degradation of cartilage tissue characterized in that the specific markers detected are fragments of degradation of type II collagen, resulting from the degradation of the amino acid sequence SEQ ID N ° 2 of the α1 chain of type II collagen located in the triple helix region, these so-called fragments degradation comprising at least four consecutive amino acids present in the Helix-II peptide of sequence SEQ ID No. 3, optionally post-translational modified. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109813911-A |
priorityDate | 2004-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.